Edwards Lifesciences Corp. EW
Health Care · Health Care Equipment & Services · NYSE · United States · edwards.com
Edwards Lifesciences Corporation is a global leader in patient-focused medical innovations for structural heart disease and critical care, headquartered in Irvine, California. The company develops, manufactures, and markets transcatheter heart valve replacement products under the SAPIEN family, transcatheter mitral and tricuspid therapies under the PASCAL and EVOQUE brands, and surgical heart valve solutions under the INSPIRIS brand. Edwards Lifesciences serves customers in the United States, Europe, Japan, and internationally with approximately 16,000 employees.
Key ratios
FreeCashFlowOnSale TTM 0.22
FreeCashFlowOnSale 2025 0.22
FreeCashFlowOnSale 2024 0.05
FreeCashFlowOnSale 2023 0.13
NetIncomeMargin TTM 0.18
NetIncomeMargin 2025 0.18
NetIncomeMargin 2024 0.77
NetIncomeMargin 2023 0.28
ReturnOnAssets TTM 0.08
ReturnOnAssets 2025 0.08
ReturnOnAssets 2024 0.08
ReturnOnAssets 2023 0.11
ReturnOnEquity TTM 0.1
ReturnOnEquity 2025 0.1
ReturnOnEquity 2024 0.17
ReturnOnEquity 2023 0.19
Recent news
Edwards' Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
2026-06-26 · Business Wire
CMS proposes Medicare coverage expansion for TAVR
2026-06-16 · Healthcare Dive